AHSN Impact Report 2022 | Page 57

Benign prostatic hyperplasia ( BPH ) – a common prostate condition for which the selected technologies will provide alternative treatment to transurethral resection of the prostate .
We are very much looking forward to building on the success of last year ’ s work and will remain as committed as ever to get these NICE-approved products to NHS patients faster .
Improving the patient experience during procedures – the chosen products will provide alternatives to otherwise more invasive and costly procedures .

“ I have been really impressed by how the PICC line and SecurAcath has transformed my experience as nurses always had problems getting a cannula in . I find it very comfortable to the point that I forget I have it and occasionally catch it . I have never had any problems with it moving position , my skin has been sore at times , caused by my treatment , but the SecurAcath has never made my skin sore . I am really glad I have it .”

Metastatic bowel cancer patient on fortnightly treatment that requires a PICC line
57 Transforming Lives Through Innovation